allocations

Improving Care Delivery for Sickle Cell Disease Patients

Statement of Need

Sickle cell disease is a substantial health issue and has a higher prevalence in people of colour, including African Americans, who are one of the most affected. Ironically, research in medical science has progressed over the decades, but Sickle cell disease patients still receive negligent treatment, primarily because many physicians are ignorant about it, and there are few facilities where such patients can access specialized treatments, and the patients suffer from stigmatization in the healthcare facilities. It is for these reasons that this proposal seeks to enhance physician education regarding the management of Sickle cell disease, improve access to Sickle cell disease specialized centres and institutes, and advocate for the ban of any forms of stigma against patients living with Sickle cell disease.

Evidence Supporting the Need

From the evidence, one can see that primary care physicians and healthcare providers do not receive proper education about Sickle cell disease: patients are diagnosed late, and the disease is treated insufficiently. For example, a study by Masese et al. (2019) describes challenges in care provisions; the majority of the emergency department personnel have acknowledged any form of deficiencies in their knowledge concerning Sickle cell disease. This lack of awareness creates not only a poor management of the disease but also a poor prognosis, as patients are key in higher pain crises, hospitalizations as well as early mortality.

However, access to such services is also a very important issue, particularly specialized care. To the study by Mburu and Odame (2019), the majority of Sickle cell disease patients do not receive care from comprehensive care centers that are required with comprehensive care centers. This lack of specialized services further complicates the situation for Sickle cell disease patients as there is poor co-ordinate care and unmet needs.

Stigma is also another factor that has a major influence on compromised care given to Sickle cell disease patients. This work by Pecker and Lanzkron (2021) maps notes that racism in the healthcare system is rife, whereby Sickle cell disease patients, especially the black ones, are seen as drug-seekers or are even denied satisfactory pain relief. This negative stereotype impacts not only the quality of care but even the effectiveness of care required by patients suffering from Sickle cell disease. As such, such patients tend to have poor trust in healthcare systems.

Understanding the Population’s Needs

The main population group at the receiving end is the Sickle cell disease patients, among Minority populations. Such patients need a more holistic approach to treatment where both the medical and the nonmedical aspects of the disease and its treatment are considered. This involves getting an opportunity to interact with professionals, institutions, and organizations in the area of health where there are competent personnel, accredited medical facilities, and progressive medical institutions which offer non-discriminative services for medical conditions related to or are caused by HIV/AIDS.

Management Theories

In order to meet these needs, the proposal for the intervention of the case will be underpinned by the theories of management. The contingency theory will help ensure that the proposed solutions are within the context of sickle cell disease patients and the environment within the health sector. This theory postulates that management should be consistent with the conditions of the particular organization or situation, which is quite essential in view of the multifaceted needs of Sickle cell disease patients (Idowu et al., 2020).

Furthermore, the tenets of transformational leadership theory will be used to influence and mobilize healthcare leaders to support the proposed change. This theory is centred around the leadership aspect, which influences change as a result of vision, enthusiasm, and guided objectives for enhancing organizational outcomes (Deng et al., 2021). By creating a culture of improvement and being empathetic, transformational leadership can contribute to developing healthcare systems where Sickle cell disease patients' needs are valued and discriminations are eliminated.

Conclusion

Due to these gaps that have been identified in awareness, access and stigma, this proposal will improve the quality of Sickle cell disease patient care by increasing their health status and their satisfaction with the services they receive. The use of management theories will ensure that the advocacy interventions that are being proposed will be proven to be appropriate and long-term in making a positive impact, helping the healthcare systems increase how they deal with Sickle cell disease.

References

August 19,2024

Dr. Urmala Roopnarinesingh

The last capstone project centers on increasing care delivery to patients with sickle cell disease through increasing the awareness of physicians, availing specialized care centers and formulating policies that will help eradicate stigma. Sickle cell disease is a substantial healthcare concern and disproportionately affects minorities. New medical discoveries of the disease show that patients with sickle cell disease continue to receive substandard treatment since physicians do not know much about the illness, few medical centers offer special treatment and negative prejudices still exist. This project will endeavour to develop an integrated strategy for these problems and, in so doing, enhance the quality of care received by these patients.

Introduction

Problem Statement

The care provided to patients with sickle cell disease is often compromised by several key issues: lack of education and information among the physicians, the lack of access to such a specialist, and the negative influence of stereotyping in the healthcare sector. These factors hinder global health goals by leading to poor health outcomes and less patient satisfaction. Indeed, according to the literature discovered for the study, including the recent work of Masese et al. (2029), physicians often lack adequate knowledge on the subject relating to sickle cell disease, so they end up being very slow to correctly diagnose the disease and develop proper management strategies. Furthermore, patients' awareness of specialized health care is a major concern because of the insufficient receipt of such services as a result of the patient's condition. The continued reinforcement of stereotypes around the illness, especially within minorities, further complicates the already difficult scenario by influencing both the care that patients receive and their experiences (Masese et al., 2019). This proposal aims to remedy these problems through the evaluation of the raised awareness level of physicians, the availability of speciality services, and the implementation of policies that ban prejudice. The aim is to provide a single and comprehensive service that will tackle the complex needs associated with sickle cell disease, thus enhancing the quality of caring for such patients and their satisfaction.

Overview of the Issue

Sickle cell disease is an inherited disease that has been known to be prevalent in African Americans and other minority group. Pain, hospitalizations, and a shortened life span are symptoms associated with the disease. Nevertheless, sickle cell disease remains relatively unnoticed and untreated because many healthcare practitioners remain unaware of the condition. As highlighted by Mburu and Odame (2019), the disease has enormous implications for the health of the population, as many exposed individuals develop complications that can lead to high mortality. In addition, the state's healthcare system, for example, lacks insurance coverage and restricts access to specialized healthcare, which only adds to the patients' burdens.

Other research scholars such as Pecker and Lanzkron (2021) opine that insurance reimbursement policies for healthcare mostly fail to cater for the costs of various necessary treatments hence straining the individuals' pockets and the limited accessibility of the services. Systematic prejudice still prevails in the healthcare system and announces itself in disparities that lead to instrumental patient mistreatment and deprivation of a positive perception of the care-receiving experience. It is, therefore, important that these concerns be addressed to enhance the quality of health of those affected with sickle cell disease and to improve the overall efficiencies of the general healthcare system. Consequently, this particular project will entail an evaluation of the current challenges and come up with solutions to the existing problem.

Target Audience

This proposal is intended for the hospital's chief executive officers, medical directors, and policymakers in the health sector. Strategic to their role, these stakeholders are instrumental in driving the change to make the care of SCD patients better. This project's findings could be useful to hospital administrators in making wise decisions that uphold ethical standards to improve patients' safety and care. This proposal seeks to enhance physicians' awareness, enhance accessibility to speciality care, and erase stereotype policies so that healthcare executives and policymakers will embrace and support the needs of patients with sickle cell disease, especially in order to improve health outcomes and satisfaction among the patients.

References

Improving Care Delivery for Sickle Cell Disease Patients

Statement of Need

Sickle cell disease is a substantial health issue and has a higher prevalence in people of colour, including African Americans, who are one of the most affected. Ironically, research in medical science has progressed over the decades, but Sickle cell disease patients still receive negligent treatment, primarily because many physicians are ignorant about it, and there are few facilities where such patients can access specialized treatments, and the patients suffer from stigmatization in the healthcare facilities. It is for these reasons that this proposal seeks to enhance physician education regarding the management of Sickle cell disease, improve access to Sickle cell disease specialized centres and institutes, and advocate for the ban of any forms of stigma against patients living with Sickle cell disease.

Evidence Supporting the Need

From the evidence, one can see that primary care physicians and healthcare providers do not receive proper education about Sickle cell disease: patients are diagnosed late, and the disease is treated insufficiently. For example, a study by Masese et al. (2019) describes challenges in care provisions; the majority of the emergency department personnel have acknowledged any form of deficiencies in their knowledge concerning Sickle cell disease. This lack of awareness creates not only a poor management of the disease but also a poor prognosis, as patients are key in higher pain crises, hospitalizations as well as early mortality.

However, access to such services is also a very important issue, particularly specialized care. To the study by Mburu and Odame (2019), the majority of Sickle cell disease patients do not receive care from comprehensive care centers that are required with comprehensive care centers. This lack of specialized services further complicates the situation for Sickle cell disease patients as there is poor co-ordinate care and unmet needs.

Stigma is also another factor that has a major influence on compromised care given to Sickle cell disease patients. This work by Pecker and Lanzkron (2021) maps notes that racism in the healthcare system is rife, whereby Sickle cell disease patients, especially the black ones, are seen as drug-seekers or are even denied satisfactory pain relief. This negative stereotype impacts not only the quality of care but even the effectiveness of care required by patients suffering from Sickle cell disease. As such, such patients tend to have poor trust in healthcare systems.

Understanding the Population’s Needs

The main population group at the receiving end is the Sickle cell disease patients, among Minority populations. Such patients need a more holistic approach to treatment where both the medical and the nonmedical aspects of the disease and its treatment are considered. This involves getting an opportunity to interact with professionals, institutions, and organizations in the area of health where there are competent personnel, accredited medical facilities, and progressive medical institutions which offer non-discriminative services for medical conditions related to or are caused by HIV/AIDS.

Management Theories

In order to meet these needs, the proposal for the intervention of the case will be underpinned by the theories of management. The contingency theory will help ensure that the proposed solutions are within the context of sickle cell disease patients and the environment within the health sector. This theory postulates that management should be consistent with the conditions of the particular organization or situation, which is quite essential in view of the multifaceted needs of Sickle cell disease patients (Idowu et al., 2020).

Furthermore, the tenets of transformational leadership theory will be used to influence and mobilize healthcare leaders to support the proposed change. This theory is centred around the leadership aspect, which influences change as a result of vision, enthusiasm, and guided objectives for enhancing organizational outcomes (Deng et al., 2021). By creating a culture of improvement and being empathetic, transformational leadership can contribute to developing healthcare systems where Sickle cell disease patients' needs are valued and discriminations are eliminated.

Conclusion

Due to these gaps that have been identified in awareness, access and stigma, this proposal will improve the quality of Sickle cell disease patient care by increasing their health status and their satisfaction with the services they receive. The use of management theories will ensure that the advocacy interventions that are being proposed will be proven to be appropriate and long-term in making a positive impact, helping the healthcare systems increase how they deal with Sickle cell disease.

References